Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
PLoS One
2022 Jan 01;174:e0267323. doi: 10.1371/journal.pone.0267323.
Show Gene links
Show Anatomy links
Recommendations for the pharmacological treatment of treatment-resistant depression: A systematic review protocol.
Gabriel FC
,
Stein AT
,
de Melo DO
,
Fontes-Mota GCH
,
Dos Santos IB
,
Rodrigues CDS
,
Rodrigues MC
,
Fráguas R
,
Florez ID
,
Correia DT
,
Ribeiro E
.
???displayArticle.abstract???
INTRODUCTION: Depression is a serious and widespread mental health disorder. Although effective treatment does exist, a significant proportion of patients with depression fail to respond to antidepressant treatment trials, a condition named treatment-resistant depression. Efficient approach should be given this condition in order to revert the burden caused by depression. Clinical practice guidelines (CPGs) are evidence-based health promotion instruments to improve diagnosis and treatment. CPGs recommendations for treatment-resistant depression must be trustworthy. The objective of the proposed study is to systematically identify, appraise the quality of CPGs for the treatment of depression and elaborate a synthesis of recommendations for treatment-resistant depression of CPGs considered to be of high quality and with high quality recommendations.
METHODS AND ANALYSIS: We will search the databases of organizations, such as PubMed, Embase, Cochrane Library, PsycInfo, and the Virtual Health Library, and organizations that develop CPGs. Three independent researchers will assess the quality of the CPGs and their recommendations using the AGREE II and AGREE-REX instruments, respectively. Given the identification of divergences and convergences as well as weak and strong points among high quality CPGs, our work may help developers, clinicians and eventually patients.
ETHICS AND DISSEMINATION: No ethical approval is required for a systematic review, as no patient data will be used. The research results will be disseminated in conferences and submitted to a peer reviewed journal.
???displayArticle.pubmedLink???
35439270
???displayArticle.link???PLoS One
Acuña-Izcaray,
Quality assessment of asthma clinical practice guidelines: a systematic appraisal.
2013, Pubmed
Acuña-Izcaray,
Quality assessment of asthma clinical practice guidelines: a systematic appraisal.
2013,
Pubmed
Alonso-Coello,
The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies.
2010,
Pubmed
Arevalo-Rodriguez,
Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review.
2013,
Pubmed
Bahn Chair,
Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.
2011,
Pubmed
Bayes,
Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation.
2018,
Pubmed
Brouwers,
AGREE II: advancing guideline development, reporting and evaluation in health care.
2010,
Pubmed
Brouwers,
Development and Validation of a Tool to Assess the Quality of Clinical Practice Guideline Recommendations.
2020,
Pubmed
Brouwers,
What to do with all the AGREEs? The AGREE portfolio of tools to support the guideline enterprise.
2020,
Pubmed
Cipriani,
Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
2018,
Pubmed
Colunga-Lozano,
Methodological assessment of Mexican Clinical Practice Guidelines: GRADE framework adherence and critical appraisal.
2021,
Pubmed
Dunner,
Prospective, long-term, multicenter study of the naturalistic outcomes of patients with treatment-resistant depression.
2006,
Pubmed
Fekadu,
What happens to patients with treatment-resistant depression? A systematic review of medium to long term outcome studies.
2009,
Pubmed
Fekadu,
A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method.
2009,
Pubmed
Gabriel,
Pharmacological treatment of depression: A systematic review comparing clinical practice guideline recommendations.
2020,
Pubmed
,
Echinobase
Graham,
2011,
Pubmed
Hoffmann-Eßer,
Guideline appraisal with AGREE II: online survey of the potential influence of AGREE II items on overall assessment of guideline quality and recommendation for use.
2018,
Pubmed
Khan,
[Cross-cultural adaptation of the instrument Appraisal of Guidelines For Research & Evaluation II (AGREE II) for assessment of clinical guidelines].
2014,
Pubmed
Knai,
Systematic review of the methodological quality of clinical guideline development for the management of chronic disease in Europe.
2012,
Pubmed
Kung,
Failure of clinical practice guidelines to meet institute of medicine standards: Two more decades of little, if any, progress.
2012,
Pubmed
Legido-Quigley,
Clinical guidelines in the European Union: mapping the regulatory basis, development, quality control, implementation and evaluation across member states.
2012,
Pubmed
MacQueen,
Systematic Review of Clinical Practice Guidelines for Failed Antidepressant Treatment Response in Major Depressive Disorder, Dysthymia, and Subthreshold Depression in Adults.
2017,
Pubmed
Molino,
Factors Associated With High-Quality Guidelines for the Pharmacologic Management of Chronic Diseases in Primary Care: A Systematic Review.
2019,
Pubmed
,
Echinobase
Mota,
[Evaluation of the Performance of the Brazilian Notification System for Health Surveillance: A Tool in Brazil's Pharmacovigilance System].
2020,
Pubmed
Nemeroff,
Prevalence and management of treatment-resistant depression.
2007,
Pubmed
Ouzzani,
Rayyan-a web and mobile app for systematic reviews.
2016,
Pubmed
Page,
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.
2021,
Pubmed
Ronsoni,
[Evaluation of eight Clinical Protocols and Therapeutic Guidelines under the Brazilian Ministry of Health using the AGREE II instrument: a pilot study].
2015,
Pubmed
Rush,
Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.
2004,
Pubmed
Saturno Hernández,
[Local variability in the guidelines for hypertension screening, diagnosis and baseline assessment in 40 health centers].
2000,
Pubmed
Semlitsch,
Evaluating Guidelines: A Review of Key Quality Criteria.
2015,
Pubmed
Siering,
Appraisal tools for clinical practice guidelines: a systematic review.
2013,
Pubmed
Watine,
Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners.
2006,
Pubmed
Wooderson,
Prospective evaluation of specialist inpatient treatment for refractory affective disorders.
2011,
Pubmed
Zafra-Tanaka,
Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review.
2019,
Pubmed
